This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Optimal NT-proBNP cut points for HFpEF rule out (optimizing sensitivity) and rule in (optimizing specificity) were derived and tested, stratified by obesity and atrialfibrillation. In our study, NT-proBNP provided little value in those with AF and dyspnea because the presence of AF is by itself a robust biomarker of HFpEF.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preservedejectionfraction during the session;"Innovations and Insights in Heart Failure With PreservedEjectionFraction: Emerging Therapies, Biomarkers and Mechanistic Studies."
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preservedejectionfraction during the session;"Innovations and Insights in Heart Failure With PreservedEjectionFraction: Emerging Therapies, Biomarkers and Mechanistic Studies."
ABSTRACT Background Left atrial (LA) myopathy is increasingly recognized as an important phenotypic trait in heart failure (HF) with preservedejectionfraction (HFpEF). There were 94 patients with events over a median follow-up of 2.9 (IQR 2.92, p = 0.01).
Beta-blockers are commonly used in patients with heart failure and mildly reduced or preservedejectionfraction (HFmrEF/HFpEF). However, there is recent concern that this type of medication may be harmful in patients with HFmrEF/HFpEF, causing exercise intolerance possibly due to exacerbation of chronotrophic incompetence.
The analysis sought to determine whether phenotypic features and treatment effects of semaglutide vary by sex in obesity-related heart failure ( HF ) with preservedejectionfraction (HFpEF). Our study sheds light on these differences and the consistent benefits of semaglutide for women and men.”
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
55 
Let's personalize your content